Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase

Pigment Cell Research

Volumn 16, Issue 2, 2003, Pages 111-116

  Cucchi, Maria Laura ^a   Frattini, Pietro ^a   Santagostino, Giuseppe ^a   Preda, Stefania ^a   Orecchia, Giovanni ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b Department of Dermatology ^*  (Italy)

Author keywords

Active phase; Monoaminergic systems; Non segmental vitiligo; Pathogenesis; Urine

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOLAMINE; DOPAMINE; FREE RADICAL; HOMOVANILLIC ACID; METADRENALIN; NORADRENALIN; NORMETADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; METABOLITE; MONOAMINERGIC SYSTEM; STRESS; URINARY EXCRETION; VITILIGO;

ADOLESCENT; ADULT; CATECHOLAMINES; CELL DEATH; CHILD; FEMALE; FREE RADICALS; HUMANS; MALE; MELANOCYTES; MIDDLE AGED; OXIDATIVE STRESS; STRESS; SYMPATHETIC NERVOUS SYSTEM; UP-REGULATION; VITILIGO;

EID: 0037566451     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2003.00015.x     Document Type: Article

References (34)

1. Boissy RE. The intrinsic (genetic) theory for the cause of vitiligo. In: Hann S-K, Nordlund JJ. Vitiligo. Oxford: Blakwell Science; 2000. pp. 123-128
2. Bystryn JC. Theories on the pathogenesis of depigmentation. In: Hann S-K, Nordlund JJ. Vitiligo. Oxford: Blakwell Science; 2000. pp. 129-136
3. Hann SK, Chun WH. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Hann S-K, Nordlund JJ. Vitiligo. Oxford: Blakwell Science; 2000. pp. 137-141
4. Schallreuter KU, Beazley WD, Wood JM. Biochemical theory of vitiligo: a role of pteridines in pigmentation. In: Hann S-K, Nordlund JJ. Vitiligo. Oxford: Blakwell Science; 2000. pp. 151-159
5. Orecchia G. Neural pathogenesis. In: Hann S-K, Nordlund JJ. Vitiligo. Oxford: Blakwell Science; 2000. pp. 142-150
6. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997;15:845-885
7. Kovacs SO. Vitiligo. Dermatology 1998;38:647-666
8. Morrone A, Picardo M, DeLuca C, Terminali O, Passi S, Ippolito F. Catecholamines vitiligo. Pigment Cell Res 1992;5:65-69
9. Schallreuter KU, Wood JM, Ziegler I, Lemke KR, Pittelkow MR, Lindsey NJ, Gutlich M. Defective tetrahydrobiopterin and catccholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1994;1226:181-192
10. Chakraborty DP, Roy S, Chakraborty AK. Vitiligo, psoralen, and melanogenesis - some observations and understanding. Pigment Cell Res 1996;9:107-116
11. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-1085
12. Cucchi ML, Frattini P, Santagostino G, Orecchia G. Higher plasma catecholamine and metabolite levels in the early phases of nonsegmental vitiligo. Pigment Cell Res 2000;13:28-32
13. Potter WZ, Muscettola G, Goodwin FK. Sources of variance in clinical studies of MHPG. In: Haas J. MHPG. Basic Mechanisms and Psychopathology. New York: Academic Press, Inc.; 1983. pp. 145-165
14. Pagliari R, Cottet-Emard JM, Peyrin L. Determination of free and conjugated normetanephrine and metanephrine in human plasma by high performance liquid chromatography with electrochemical detection. J Chromatogr Biomed Appl 1991;563:23-36
15. Santagostino G, Frattini P, Schinelli S, Corona GL. Urinary 3-methoxy-4-hydroxyphenylglycol determination using reversed-phase chromatography with amperometric detection. J Chromatogr 1982;233:89-95
16. Frattini P, Santagostino G, Schinelli S, Cucchi ML, Corona GL. Assay of urinary vanilmandelic, homovanillic and 5-hydroxyindolacetic acids by liquid chromatography with electrochemical detection. J Pharmacol Methods 1983;10:193-198
17. Hann SK, Park YK, Chun WH. Clinical features of vitiligo. Clin Dermatol 1997;15:891-897
18. Orecchia G, Cucchi ML, Frattini P, Santagostino G. Urinary catecholamines in non-segmental vitiligo. 9th Annual ESPCR Meeting, Ulm September 27-October 1, 2000 (Abstract vit-12). Pigment Cell Res 2000;13:403
19. Schallreuter KU, Wood JM, Pittelkow MR, Buttner G, Swanson N, Korner C, Ehrke C. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Acta Dermatol Res 1996;288:14-18
20. LePoole C, Van den Wijngaard R, Smit NPM, Oosting J, Westerhof W, Pavel S. Catechol-O-methyl transferase in vitiligo. Arch Dermatol Res 1994;286:81-86
21. Kopin IJ. Origins and significance of dopa and catecholamine metabolites in body fluids. Pharmacopsychiatry 1992;25:22-36
22. Bir LS, Aktan S. Sympathetic skin response in psoriasis and vitiligo. J Auton Nerv Syst 1999;77:68-71
23. Wu CS, Yu HS, Chang HR, Yu CL, Wu BN. Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesion. J Derm Sci 2000;23:53-62
24. Ionescu G, Kiehl R. Increased plasma norepinephrine in psoriasis. Acta Derm Venereol 1991;71:169-170
25. Schmid-Ott G, Jacobs R, Jager B, Klages S, Wolf J, Werfel T, Kapp A, Schurmeyer T, Lamprecht F, Schmidt RE, Schedlowski M. Stressinduced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary study. Psychother Psychosom 1998;67:37-42
26. Weigl BA. The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol 2000;39:678-688
27. Schulpis K, Georgala S, Papakonstantinou ED, Michas T. Psychological and sympatho-adrenal status in patients with cystic acne. J Eur Acad Dermatol Venereol 1999;13:24-27
28. Puchalsky Z. Anxiety structure and catecholamine parameters in patients with rosacea, alopecia areata and lichen ruber planus. Z Hautkr 1986;61:137-145
29. Alexandrova M. Stress induced tyrosine aminotranferase activity via glucocorticoid receptor. Horm Metab Res 1994;26:97-99
30. Roychowdhury SK, Chakraborty DP. Some urinary indole profile of vitiliginous patients. Clinica Chimica Acta 1968;22:298-300
31. Bindoli A, Rigobello MP, Deeble DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Rad Biol Med 1992;13:391-405
32. 2) accumulation in the epidermis of patients with vitiligo and ist successful removal by a UVB-activated pseudocatalase. J Invest Dermatol 1999;4:91-96
33. Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001;144:55-65
34. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999;141:301-303